|
|
U.S. Neurosurgical, Inc. - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for U.S. Neurosurgical, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
U.S. Neurosurgical, Inc.. The Group's principal activity is to own and operate stereotactic radiosurgery centers, utilizing the Gamma Knife technology. The Gamma Knife is a radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates two Gamma Knife centers in Kansas City and New York. It's target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to use gamma knife. It operates throughout the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|